Lancet Neurology

Neuroscience

New blood test for Alzheimer's developed

A new blood test for Alzheimer's disease has been developed under the leadership of researchers at the University of Gothenburg. The method is based on measuring a specific variant of tau protein in ordinary blood samples, ...

Neuroscience

A potential treatment for life-threatening neurological diseases

A group of life-threatening neurological conditions affecting children has been linked to an antibody that points to potential treatment, according to an observational multicenter study involving 535 children with central ...

Alzheimer's disease & dementia

The global burden of dementia has doubled since 1990

The number of people living with dementia globally more than doubled between 1990 and 2016 from 20.2 million to 43.8 million, prompting researchers to call for more preventative action.

Parkinson's & Movement disorders

Restless sleep may be an early sign of Parkinson's disease

Restless sleep could be a sign of a disorder associated with diseases of the brain. Researchers from Aarhus University conducted a case-control study on the condition of the dopamine-producing nerve cells in the brain and ...

Medications

Trial results of new drug for generalized myasthenia gravis

Argenx, a Belgium pharmaceutical company, recently announced that The Lancet Neurology has published pivotal trial results from the Phase 3 ADAPT trial of efgartigimod, an FcRn antagonist, for the treatment of adults living ...

page 7 from 21